FTCM
IBER

First Trust Capital Management’s Ibere Pharmaceuticals IBER Stock Holding History

First Trust Capital Management’s Portfolio IBER Stock Details IBER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-542,852
Closed -$5.48M – 360
2022
Q4 		$5.48M Hold
542,852
– – 0.29% 106
2022
Q3 		$5.38M Buy
+542,852
New +$5.35M 0.25% 117

First Trust Capital Management's IBER Position: Q1 2023 in Review

First Trust Capital Management sold out of Ibere Pharmaceuticals (IBER) in Q1 2023, closing a stake of 542,852 shares — an estimated $5.48M sold.

First Trust Capital Management first reported a position in IBER in Q3 2022 and held it in 2 quarters. The position peaked at $5.48M in Q4 2022. 0 funds tracked by Wall St. Rank hold IBER as of Q1 2023.

  • First Trust Capital Management reported no remaining Ibere Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • First Trust Capital Management sold 542,852 Ibere Pharmaceuticals shares in Q1 2023, an estimated $5.48M.
  • First Trust Capital Management first reported a position in Ibere Pharmaceuticals in Q3 2022 and held it in 2 quarters.
  • First Trust Capital Management's Ibere Pharmaceuticals position peaked at $5.48M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Ibere Pharmaceuticals as of Q1 2023.

Based on First Trust Capital Management's 13F filing for Q1 2023, filed 12 May 2023.